Gene Expression Regulation, Neoplastic

"Gene Expression Regulation, Neoplastic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue.

Descriptor ID	D015972
MeSH Number(s)	G05.308.370
Concept/Terms	Gene Expression Regulation, Neoplastic Gene Expression Regulation, Neoplastic Regulation of Gene Expression, Neoplastic Regulation, Gene Expression, Neoplastic Neoplastic Gene Expression Regulation

Below are MeSH descriptors whose meaning is more general than "Gene Expression Regulation, Neoplastic".

Biological Sciences [G]
Genetic Phenomena [G05]
Gene Expression Regulation [G05.308]
Gene Expression Regulation, Neoplastic [G05.308.370]

Below are MeSH descriptors whose meaning is more specific than "Gene Expression Regulation, Neoplastic".

Gene Expression Regulation, Neoplastic
Gene Expression Regulation, Leukemic

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Gene Expression Regulation, Neoplastic" by people in this website by year, and whether "Gene Expression Regulation, Neoplastic" was a major or minor topic of these publications.

Bar chart showing 250 publications over 25 distinct years, with a maximum of 25 publications in 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	0	1	1
1995	1	0	1
1996	1	2	3
1999	1	0	1
2000	0	2	2
2001	0	2	2
2002	2	0	2
2003	1	6	7
2004	1	6	7
2005	1	7	8
2006	0	2	2
2007	4	4	8
2008	8	7	15
2009	6	8	14
2010	5	8	13
2011	7	11	18
2012	6	4	10
2013	6	13	19
2014	7	9	16
2015	9	12	21
2016	8	17	25
2017	5	12	17
2018	5	11	16
2019	4	7	11
2020	4	7	11

Below are the most recent publications written about "Gene Expression Regulation, Neoplastic" by people in Profiles.

Zeng B, Glicksberg BS, Newbury P, Chekalin E, Xing J, Liu K, Wen A, Chow C, Chen B. OCTAD: an open workspace for virtually screening therapeutics targeting precise cancer patient groups using gene expression features. Nat Protoc. 2021 02; 16(2):728-753.

View in: PubMed
Gunay G, Kirit HA, Kamatar A, Baghdasaryan O, Hamsici S, Acar H. The effects of size and shape of the ovarian cancer spheroids on the drug resistance and migration. Gynecol Oncol. 2020 11; 159(2):563-572.

View in: PubMed
Rao G, Dwivedi SKD, Zhang Y, Dey A, Shameer K, Karthik R, Srikantan S, Hossen MN, Wren JD, Madesh M, Dudley JT, Bhattacharya R, Mukherjee P. MicroRNA-195 controls MICU1 expression and tumor growth in ovarian cancer. EMBO Rep. 2020 10 05; 21(10):e48483.

View in: PubMed
Raguraman R, Parameswaran S, Kanwar JR, Vasudevan M, Chitipothu S, Kanwar RK, Krishnakumar S. Gene expression profiling of tumor stroma interactions in retinoblastoma. Exp Eye Res. 2020 08; 197:108067.

View in: PubMed
Dang TT, Morales JC. Involvement of POLA2 in Double Strand Break Repair and Genotoxic Stress. Int J Mol Sci. 2020 Jun 15; 21(12).

View in: PubMed
Sui Y, Li X, Oh S, Zhang B, Freeman WM, Shin S, Janknecht R. Opposite Roles of the JMJD1A Interaction Partners MDFI and MDFIC in Colorectal Cancer. Sci Rep. 2020 05 26; 10(1):8710.

View in: PubMed
Chandrakesan P, Panneerselvam J, May R, Weygant N, Qu D, Berry WR, Pitts K, Stanger BZ, Rao CV, Bronze MS, Houchen CW. DCLK1-Isoform2 Alternative Splice Variant Promotes Pancreatic Tumor Immunosuppressive M2-Macrophage Polarization. Mol Cancer Ther. 2020 07; 19(7):1539-1549.

View in: PubMed
Yan J, Yu S, Jia C, Li M, Chen J. Molecular subtyping in pancreatic neuroendocrine neoplasms: New insights into clinical, pathological unmet needs and challenges. Biochim Biophys Acta Rev Cancer. 2020 08; 1874(1):188367.

View in: PubMed
Dawson NA, Zibelman M, Lindsay T, Feldman RA, Saul M, Gatalica Z, Korn WM, Heath EI. An Emerging Landscape for Canonical and Actionable Molecular Alterations in Primary and Metastatic Prostate Cancer. Mol Cancer Ther. 2020 06; 19(6):1373-1382.

View in: PubMed
Mitra S, Lauss M, Cabrita R, Choi J, Zhang T, Isaksson K, Olsson H, Ingvar C, Carneiro A, Staaf J, Ringnér M, Nielsen K, Brown KM, Jönsson G. Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma. Mol Oncol. 2020 05; 14(5):933-950.

View in: PubMed

People

Explore

Similar Concepts

Top Journals